KRAS and colorectal carcinoma: The prevalence of Kirsten rat sarcoma viral oncogene (KRAS) mutations in MOC is slightly higher compared to mucinous and non-mucinous colorectal carcinomas, with mutations observed in 43–46% of MOC cases versus 30% of mucinous colorectal tumors.